North Point Portfolio Managers’s Eli Lilly LLY Stock Holding History

North Point Portfolio Managers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Buy	1,473 +148	+11%	+$150K	0.24%	41
2025 Q4	$1.42M	Sell	1,325 -500	-27%	-$478K	0.24%	39
2025 Q3	$1.39M	Sell	1,825 -1	-0.1%	-$744	0.23%	40
2025 Q2	$1.42M	Hold	1,826	–	–	0.24%	40
2025 Q1	$1.51M	Buy	1,826 +1,100	+152%	+$915K	0.26%	40
2024 Q4	$560K	Sell	726 -4,400	-86%	-$3.64M	0.1%	49
2024 Q3	$4.54M	Buy	5,126 +4,220	+466%	+$3.79M	0.73%	40
2024 Q2	$820K	Buy	906 +180	+25%	+$144K	0.14%	44
2024 Q1	$565K	Buy	726 +47	+7%	+$33.4K	0.1%	47
2023 Q4	$396K	Buy	679 +154	+29%	+$89.9K	0.07%	48
2023 Q3	$282K	Buy	525 +62	+13%	+$31.9K	0.06%	47
2023 Q2	$217K	Sell	463 -1,166	-72%	-$489K	0.04%	48
2023 Q1	$559K	Hold	1,629	–	–	0.09%	45
2022 Q4	$596K	Hold	1,629	–	–	0.1%	43
2022 Q3	$527K	Sell	1,629 -12	-0.7%	-$3.8K	0.1%	46
2022 Q2	$532K	Hold	1,641	–	–	0.09%	45
2022 Q1	$470K	Hold	1,641	–	–	0.07%	48
2021 Q4	$453K	Hold	1,641	–	–	0.06%	48
2021 Q3	$379K	Sell	1,641 -15	-0.9%	-$3.7K	0.05%	50
2021 Q2	$380K	Hold	1,656	–	–	0.05%	54
2021 Q1	$309K	Hold	1,656	–	–	0.04%	59
2020 Q4	$280K	Sell	1,656 -10	-0.6%	-$1.49K	0.04%	56
2020 Q3	$247K	Hold	1,666	–	–	0.04%	56
2020 Q2	$274K	Hold	1,666	–	–	0.05%	50
2020 Q1	$231K	Hold	1,666	–	–	0.05%	53
2019 Q4	$219K	Buy	+1,666	New	+$193K	0.04%	69
2019 Q2	–	Sell	-1,666	Closed	-$216K	–	79
2019 Q1	$216K	Sell	1,666 -1,659	-50%	-$202K	0.04%	68
2018 Q4	$385K	Sell	3,325 -900	-21%	-$101K	0.09%	44
2018 Q3	$453K	Hold	4,225	–	–	0.08%	44
2018 Q2	$361K	Hold	4,225	–	–	0.06%	46
2018 Q1	$327K	Hold	4,225	–	–	0.06%	51
2017 Q4	$357K	Hold	4,225	–	–	0.06%	48
2017 Q3	$361K	Hold	4,225	–	–	0.06%	45
2017 Q2	$348K	Sell	4,225 -600	-12%	-$49K	0.06%	44
2017 Q1	$406K	Hold	4,825	–	–	0.07%	41
2016 Q4	$355K	Hold	4,825	–	–	0.07%	42
2016 Q3	$387K	Hold	4,825	–	–	0.07%	41
2016 Q2	$380K	Hold	4,825	–	–	0.07%	41
2016 Q1	$347K	Hold	4,825	–	–	0.07%	44
2015 Q4	$407K	Hold	4,825	–	–	0.08%	41
2015 Q3	$404K	Hold	4,825	–	–	0.08%	41
2015 Q2	$403K	Hold	4,825	–	–	0.07%	42
2015 Q1	$351K	Hold	4,825	–	–	0.07%	44
2014 Q4	$333K	Hold	4,825	–	–	0.06%	45
2014 Q3	$313K	Hold	4,825	–	–	0.06%	49
2014 Q2	$300K	Hold	4,825	–	–	0.06%	55
2014 Q1	$284K	Hold	4,825	–	–	0.06%	55
2013 Q4	$246K	Sell	4,825 -2,935	-38%	-$147K	0.05%	56
2013 Q3	$391K	Hold	7,760	–	–	0.09%	46
2013 Q2	$381K	Buy	+7,760	New	+$422K	0.1%	44

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

North Point Portfolio Managers's LLY Position: Q1 2026 in Review

North Point Portfolio Managers increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $150K and bringing the position to 1,473 shares worth $1.35M. The position accounts for 0.24% of the portfolio, ranked #41.

North Point Portfolio Managers first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.54M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

North Point Portfolio Managers held 1,473 shares of Eli Lilly worth $1.35M as of Q1 2026.
North Point Portfolio Managers bought 148 Eli Lilly shares in Q1 2026, an estimated $150K.
Eli Lilly made up 0.24% of North Point Portfolio Managers's portfolio in Q1 2026, its #41 holding.
North Point Portfolio Managers first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
North Point Portfolio Managers's Eli Lilly position peaked at $4.54M in Q3 2024.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on North Point Portfolio Managers's 13F filing for Q1 2026, filed 24 Apr 2026.